Archive for April 2013
VC Says There Are Many ‘Unmet Needs’ in Ophthalmology Space
SAN FRANCISCO — The second annual Ophthalmology Innovation Summit (OIS) was held in conjunction with the American Society of Cataract and Refractive Surgeons (ASCRS; Reston, Virginia). International Business Forum (Massapequa, New York) organized the meeting. The purpose of the OIS conference is to support innovation by facilitating deal-flow and business partnerships between CEOs of young…
Read MoreOIS@ASCRS 2013 Executive Summary – Eye on Innovation
The Second Annual OIS@ASCRS – Ophthalmology Innovation Summit at the American Society of Cataract and Refractive Surgery was held in San Francisco on April 18, 2013. The conference attracted 325 attendees from 29 US states and 21 countries. The purpose of OIS is to create an ecosystem of clinical, technology and business. Uniting this diverse…
Read MoreOIS Sets Sights on Anterior Segment Innovations
The second annual Ophthalmology Innovation Summit (OIS) at the 2013 ASCRS•ASOA Symposium & Congress combined industry, clinicians, and entrepreneurs to highlight innovations in anterior segment surgery. The half-day session featured talks on the impact of femtosecond lasers and intraoperative aberrometry, as well as micro-invasive glaucoma surgery (MIGS). Co-chairman William J. Link, PhD, Versant Ventures, Menlo…
Read MoreAll Eyes on Ophthalmic Innovation: An Interview with Bill Link
The ophthalmology drug, device and medical technology sector is poised for continued growth, as innovators and entrepreneurs unblinkingly stare down the ongoing domino effect being caused by an aging population, which begets a proliferation in eye disease incidence, which, in turn, begets an unprecedented patient base that consequently requires the types of novel ophthalmic products…
Read MoreInnovation in Ophthalmology Pushes Forward
SAN FRANCISCO — The future of innovation in ophthalmology is promising, with more forward movement than drag, according to a speaker here. “The tailwinds are stronger than the headwinds,” William J. Link, PhD, managing director of Versant Ventures, told colleagues interested in supporting innovation in the ophthalmic space at the Ophthalmology Innovation Summit. Key criteria…
Read MoreFDA – Medical Device Pathway: Tough Questions, Clear Answers
Tackling some of the most difficult topics surrounding medical devices and approval with the FDA, Bill Link, Managing Director for Versant Ventures leads Malvina Eydelman, Director for the FDA’s Division of Ophthalmic and Ear, Nose and Throat Devices, through an interview that brings her highly diverse and expert knowledge to the forefront for attendees of…
Read MoreFunding Ophthalmic Innovation
Angela MacFarlane, President & CEO for ForSight Labs and Emmett Cunningham, Partner for Clarus Ventures co-moderate a segment on funding opportunities for innovative products and procedures in the Ophthalmic space, at the 2nd Annual Ophthalmology Innovation Summit on April 18, 2013. Lending their expert insights on the funding process are panelists Calvin W. Roberts, MD,…
Read MoreMIGS: Micro-Invasive Glaucoma Surgery – Challenges & Opportunities
Bringing together a diverse range of experts for the panel discussion on MIGS at the 2nd Annual Ophthalmology Innovation Summit, co-moderators Tom Samuelson of Minnesota Eye Consultants and Kerry Solomon of Carolina Eyecare Research Institute, lead panelists Tom Burns of Glaukos Corporation, Ron Bache of AqueSys, Inc, David Van Meter of Ivantis, Brian Walsh of…
Read MoreClinical Overview of MIGS
Addressing the attendees at the 2nd Annual Ophthalmology Innovation Summit with a clinical overview of Micro-Invasive Glaucoma Surgery, Ike K. Ahmed, MD and Assistant Professor for the University of Toronto, details the transition from glaucoma medication to micro-invasive surgery and some of the devices contributing to the successes of this procedure. Presenter: Ike Ahmed, MD…
Read MoreIntroduction to MIGS: Micro-Invasive Glaucoma Surgery
Dr. Gil Kliman, Managing Director for InterWest Partners, introduces the conference’s segment on MIGS at the 2nd Annual Ophthalmology Innovation Summit on April 18, 2013. Giving the attendees an overview of the market and an in depth view of the different approaches, Gil sets the stage for further discussion around Micro-Invasive Glaucoma Surgery. Presenter: Gilbert…
Read More2013 OIS Ophthalmology Innovation Award Ceremony
Bill Link, Managing Director for Versant Ventures presents the first ever “Eye on Innovation Award” during the 2nd Annual Ophthalmology Innovation Summit on April 18, 2013. Expressing the importance of SecondSight’s upcoming technology, Bill provides a brief explanation of the company’s achievement before inviting them to accept the award and present on their innovative technology.…
Read MoreSurgical Treatment of Presbyopia – Challenges and Opportunities
Requesting many highly sought after answers to questions surrounding the surgical treatment of Presbyopia, co-moderators Dick Lindstrom, Founder and Attending Surgeon for Minnesota Eye Consultants and Eugene de Juan, Jr., MD, Founder & Vice-Chairman for ForSight Labs, dig into the underlying challenges and emerging possibilities in Presbyopia surgery. Lending their expertise to provide attendees with…
Read More